Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Megan Marcotulli"'
Autor:
Maro Ohanian, Farhad Ravandi, Maria E Suarez-Almazor, Noha Abdel-Wahab, Houssein Safa, Ala Abudayyeh, Stephen Gruschkus, May Daher, Richard Champlin, Kaysia Ludford, Guillermo Garcia-Manero, Hind Rafei, Jacinth Joseph, Gabriela Rondon, Laura Whited, Faisal Fa'ak, Cristina Knape, Mahran Shoukier, Megan Marcotulli, Alison M Gulbis, Betul Oran, Uday R Popat, Rotesh Mehta, Amin M Alousi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021)
Background Immune checkpoint inhibitors (ICIs) are being used after allogeneic hematopoietic stem cell transplantation (alloHCT) to reverse immune dysfunction. However, a major concern for the use of ICIs after alloHCT is the increased risk of graft-
Externí odkaz:
https://doaj.org/article/10e93fbbcd6b4e969d6a3f82162fa2d6
Autor:
Gheath Alatrash, Farhad Ravandi, Rohtesh S. Mehta, Stephen K. Gruschkus, Betul Oran, May Daher, Cristina Knape, Chantal Saberian, Ala Abudayyeh, Guillermo Garcia-Manero, Richard E. Champlin, Amin M. Alousi, Megan Marcotulli, Noha Abdel-Wahab, Laura K. Whited, Jacinth Joseph, Gabriela Rondon, Hind Rafei, Alison M. Gulbis, Maro Ohanian, Adi Diab, Uday R. Popat, Marina Konopleva, Naval Daver
Publikováno v:
Blood. 136:1-1
Background: Allogeneic hematopoietic stem cell transplantation (alloHCT) remains a curative approach for patients with AML/MDS. Still, up to 50 % of patients relapse after alloHCT. Immune checkpoint inhibitors (ICI) are being used in the post-transpl